-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...

-Frontline   The United Nation's MDG report 2014 shows that despite India's significant economic progress, around one-third of the world's extremely poor people reside in the country. IT is raining development goals. As the period for the Millennium Development Goals (MDGs) draws to a close next year, discussions around these goals and what should replace them have reached fever pitch, with national governments, international organisations and representatives of civil society participating in them. Of...

-The Times of India MUMBAI: Treatment for HIV patients across India has taken a hit, especially in Delhi and Mumbai, due to severe stock-outs of life-saving medicines reported at government-owned centres. Shortage of first-line (initial), second-line (advanced) and paediatric HIV drugs, besides crucial diagnostic kits, has prompted patient groups to send a legal notice to the government, pointing to the scarcity, gaps in procurement and supply of these drugs. The treatment and control...

-Down to Earth Going by current trends, the target for reducing infant mortality and improving other human development indices seem near impossible to achieve Less that 500 days are left for nations to achieve the targets set under the United Nations' Millennium Development Goals (MDGs); there are eight such goals which range from halving extreme poverty rates to halting the spread of HIV/AIDS and providing universal primary education. The countdown for the deadline...

-PTI   India is the lowest performing country among the BRICS nations in all categories of the HDI with the exception of life expectancy, which is lower in South Africa as a result of the HIV/AIDS epidemic  In a sign that shows India has a lot of catching up to do, the country's ranking in the Human Development Index (HDI) remained unchanged at 135 in 2013, reflecting little improvement in the living standard...